Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Estradiol/Nomegestrol Acetate in Postmenopausal Women
NCT03749733Phase 1Withdrawn
- Sponsor
- Grünenthal GmbH
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estradiol and nomegestrol in contraception (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Area under the plasma concentration-time curve from time zero to time t (Total estrone, corrected) at 72 hours, Area under the plasma concentration-time curve from time zero to time t (Total estradiol, corrected) at 72 hours and 4 more. Planned start Oct 2019; status: withdrawn.
02
Drugs
estradiolnomegestrol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03749733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03749733.